Trademark Overview
On Monday, November 25, 2024, a trademark application was filed for GENTIJECT with the United States Patent and Trademark Office. The USPTO has given the GENTIJECT trademark a serial number of 98870971. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 25, 2024. This trademark is owned by Sun Pharmaceutical Industries Limited. The GENTIJECT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders; Pharmaceutical preparations for the treatment of cancer